These questions led to the formation of Project Mercury, a patient-led collaborative global initiative to ensure timely access to effective and affordable treatments for people affected by facioscapulohumeral muscular dystrophy (FSHD) everywhere.
The Global Task Force (GTF) convened in Vancouver for its sixth meeting, bringing together international leaders, patient advocates, and industry partners in a hybrid format to review progress and define the next phase of Project Mercury. The two-day session underscored the initiative’s unwavering commitment to accelerating global readiness for facioscapulohumeral
Project Mercury is built on the conviction that meaningful change in FSHD research and care must be driven by those most affected—patients, families, and the communities that support them. At the heart of this global initiative are the Country Working Groups (CWGs), where national voices converge to shape international impact.
Project Mercury is built on the conviction that meaningful change in FSHD research and care must be driven by those most affected—patients, families, and the communities that support them. At the heart of this global initiative are the Country Working Groups (CWGs), where national voices converge to shape international impact.